Single-arm phase II study of low-dose paclitaxel and pembrolizumab in platinum-refractory metastatic urothelial carcinoma (UC).

被引：2
|
作者：
Bitting, Rhonda L. [1 ]
Vile, Donald Charles [2 ]
Tooze, Janet A. [3 ]
Thomas, Christopher Y. [1 ]
Neve, Morgan [1 ]
Kooshki, Mitra [1 ]
Brown, Jessica [4 ]
Dubey, Purnima [4 ]
Triozzi, Pierre [1 ]
Goodman, Michael Moses [1 ]
机构：
[1] Wake Forest Baptist Hlth, Ctr Comprehens Canc, Winston Salem, NC USA
[2] Wake Forest Baptist Hlth, Winston Salem, NC USA
[3] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[4] Ohio State Univ, Pelotonia Inst Immunooncol, James Comprehens Canc Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.433
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
433
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer
    Chalasani, Pavani
    Farr, Kiah
    Wu, Vicky
    Jenkins, Isaac
    Liu, Alex
    Parker, Stephanie
    Gadi, Vijayakrishna K.
    Specht, Jennifer
    Linden, Hannah
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 188 (01) : 91 - 99
  • [42] Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer
    Pavani Chalasani
    Kiah Farr
    Vicky Wu
    Isaac Jenkins
    Alex Liu
    Stephanie Parker
    Vijayakrishna K. Gadi
    Jennifer Specht
    Hannah Linden
    Breast Cancer Research and Treatment, 2021, 188 : 91 - 99
  • [43] Phase II study of low-dose docetaxel/fluorouracil/cisplatin in metastatic gastric carcinoma
    Park, SR
    Chun, JH
    Kim, YW
    Lee, JH
    Choi, IJ
    Kim, CG
    Lee, JS
    Bae, JM
    Kim, HK
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (05): : 433 - 438
  • [44] A phase II, multicenter, single-arm trial of CV301 plus atezolizumab (Atezo) in locally advanced (unresectable) or metastatic urothelial cancer (UC).
    Sonpavde, Guru
    Maughan, Benjamin Louis
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Kilbridge, Kerry L.
    Lee, Richard J.
    Yu, Evan
    Schweizer, Michael Thomas
    Montgomery, Robert B.
    Cheng, Heather H.
    Hsieh, Andrew Caleb
    Birhiray, Ruemu E.
    Gabrail, Nashat Y.
    Nemunaitis, John J.
    Rezazadeh, Arash
    Van Veldhuizen, Peter J.
    Vogelzang, Nicholas J.
    Heery, Christopher Ryan
    Grivas, Petros
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [45] Modified-dose capecitabine plus bevacizumab for the treatment of advanced/metastatic hepatocellular carcinoma (HCC): A phase II, single-arm study
    Hsu, C.
    Yang, T.
    Hsu, C.
    Toh, H.
    Epstein, R. J.
    Hsiao, L.
    Cheng, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
    Saloura, Vassiliki
    Cohen, Ezra E. W.
    Licitra, Lisa F.
    Billan, Salem
    Dinis, Jose
    Lisby, Steen
    Gauler, Thomas Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] A PHASE II SINGLE-ARM SAFETY STUDY OF ELOTUZUMAB IN COMBINATION WITH THALIDOMIDE AND LOW DOSE DEXAMETHASONE IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
    Mateos, M. V.
    Granell, M.
    Oriol Rocafiguera, A.
    Martinez Lopez, J.
    Blade, J.
    Hernandez, M. T.
    Martin Sanchez, J.
    Gironella, M.
    Lynch, M.
    Bleickardt, E.
    Paliwal, P.
    Singhal, A.
    San Miguel, J.
    HAEMATOLOGICA, 2014, 99 : 361 - 362
  • [48] An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
    Vassiliki Saloura
    Ezra E. W. Cohen
    Lisa Licitra
    Salem Billan
    Jose Dinis
    Steen Lisby
    Thomas C. Gauler
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1227 - 1239
  • [49] An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
    Saloura, Vassiliki
    Cohen, Ezra E. W.
    Licitra, Lisa
    Billan, Salem
    Dinis, Jose
    Lisby, Steen
    Gauler, Thomas C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) : 1227 - 1239
  • [50] Anlotinib in patients with recurrent platinum-resistant or refractory ovarian carcinoma: A prospective, single-arm, single-center, phase II clinical study.
    Wang, Huaying
    Shen, Wenbin
    Shan, Boer
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345